Skip to main content

Table 2 Humoral immune response to BNT162b2 vaccination according to serum IgG anti-spike protein antibody levels

From: Low humoral immune response to the BNT162b2 vaccine against COVID-19 in nursing home residents undergoing hemodialysis: a case–control observational study

 

Nursing home residents (n = 26)

Control group (n = 184)

p value

Seronegative 3 weeks after the 1st dose (< 0.8 U/mL) (number, %)

20, 77%

1, 0.5%

< 0.001

Seronegative 2 weeks after the 2nd dose (< 0.8 U/mL) (number, %)

4, 15%

0, 0%

< 0.001

Seronegative 3 weeks after the 2nd dose (< 0.8 U/mL) (number, %)

2, 8%

0, 0%

0.004